# Common Sugar Fructose May Facilitate Ovarian Cancer Metastasis Researchers discover fructose signals help chemotherapy-surviving cancer cells detach and spread throughout the body. - **Source:** [ScienceDaily – Health](https://www.sciencedaily.com/news/health_medicine) - **Published:** 2026-11-12 - **Topic:** [health](https://brifing.si/c/health) - **Original article:** - **On Brifing:** https://brifing.si/s/c1611603-6775-4d06-a76e-736e5f17867a ## Chemotherapy Survivors Signal Spread Researchers at The Wistar Institute identified that ovarian cancer cells surviving chemotherapy remain biologically active. These cells release fructose, which acts as a chemical signal to neighboring tumor cells. This process encourages cancer cells to break free from their original location, potentially driving the recurrence that plagues many ovarian cancer patients. ## Fructose as a Messenger Fructose, commonly found in high-fructose corn syrup and various processed foods, functions as more than just an energy source. In this study, it acted as a signaling molecule that promotes metastasis. Preclinical models showed that high fructose intake could trigger these cancer-spreading signals even in the absence of prior chemotherapy treatment. ## Mechanism of Cellular Detachment The study utilized CRISPR screening to reveal that fructose suppresses cholesterol production in nearby cancer cells. Cholesterol is vital for maintaining cell membrane integrity and the biological glue that holds cells together. By reducing cholesterol, fructose weakens these connections, allowing cancer cells to detach more easily and migrate to other abdominal organs. ## Statins and Cancer Risk The discovery regarding cholesterol led researchers to investigate statins, which are widely prescribed to lower cholesterol levels in millions of patients. Experiments indicated that statins might similarly weaken connections between cancer cells. Scientists are now exploring whether these medications could inadvertently influence the effectiveness of chemotherapy treatments in certain patient populations. ## Scope of Clinical Implications While the research focused on ovarian cancer, the team suspects this biological mechanism may apply to other abdominal cancers. Pancreatic, colon, and liver cancers could potentially behave in a similar manner. Researchers are currently designing new experiments to determine if these findings hold true across these other types of aggressive malignant diseases. ## Dietary and Medical Caution The researchers emphasize that these findings do not prove that eating sugar causes cancer spread in humans. Furthermore, patients currently taking statins should not discontinue their prescribed medication based on this preclinical data. Additional research is required to establish whether dietary modifications or changes to medication regimens could improve clinical outcomes. ## Metastasis Remains Primary Challenge Metastasis is responsible for approximately 90% of ovarian cancer deaths, making it a critical focus for oncology research. Understanding how cancer cells escape their original site is essential for developing better treatments. This study provides a new perspective on how nutrients and metabolic processes influence the dangerous ability of tumors to spread. ## Future Research Directions The Wistar Institute team is now working to reproduce these results in various cancer models. By identifying fructose as a key signal in the metastatic process, scientists hope to develop novel therapeutic strategies. Future studies will aim to clarify the complex relationship between diet, cholesterol regulation, and the progression of cancer. ## Sources covering this story - https://www.sciencedaily.com/releases/2026/11/261111221501.htm — --- _Summary written by Brifing from the original reporting. Copyright in the original article belongs to its publisher; read the full piece at the link above._